SILK ROAD THERAPEUTICS
Clinical stage company focused on rare diseases and 505b2 regulatory pathway. Our lead product SRT-001 ($200M annual revenue potential determined by independent third party) for Behcet's Disease showed very promising results at the Phase 2 proof-of-concept trial. The results of the trial were presented at American College of Rheumatology annual meeting on November 2019. On January 2020, our second product SRT-002 received a "May Proceed" letter from FDA for starting a Phase 2 proof-of-concept trial in the US.
SILK ROAD THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Life Science
Founded:
2018-01-01
Address:
Washington, District Of Columbia, United States
Country:
United States
Website Url:
http://www.silkroadtx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Google Apps For Business Squarespace Hosted NSONE
Similar Organizations
Avogadro Development Corp
A clinical-stage biotechnology company focused on pattern recognition receptors in immunometabolic disease.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Stemmatters
Stemmatters is a biotechnology company focused on regenerative medicine.
Current Employees Featured
Founder
